InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lager Joanne Jenkins, Directrice Médicale. Insider active across 1 company, notably iTeos Therapeutics, Inc.. In total, 7 filings have been published. History available since 18 November 2021. The latest transaction was disclosed on 11 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
3,500 shares@ US$4.303.4% of flowCommon StockSEC:0001209191-22-018669:0
3,500 shares@ US$4.303.3% of flowCommon StockSEC:0001209191-22-009568:0
3,500 shares@ US$4.303.3% of flowCommon StockSEC:0001209191-22-003605:0
7,000 shares@ US$4.306.6% of flowCommon StockSEC:0001209191-22-001340:0
7,000 shares@ US$4.306.7% of flowCommon StockSEC:0001209191-21-070453:0
3,500 shares@ US$4.303.3% of flowCommon StockSEC:0001209191-21-069136:0
28,000 shares@ US$4.3026.7% of flowCommon StockSEC:0001209191-21-065977:0
7 of 7 declarations
About Lager Joanne Jenkins
Joanne Jenkins Lager is the Chief Medical Officer of iTeos Therapeutics, Inc. She is responsible for leading the company's medical initiatives, ensuring the integration of clinical research and drug development strategies.
